|
KQB198 Clinical Trials
3 actively recruiting trials across 3 locations
No change since May 2026
Pipeline
Phase 1: 2Phase 2: 1
Top Sponsors
- Kumquat Biosciences Inc.3
Indications
- Cancer3
- Gastro Intestinal Stromal Tumour1
- GIST Metastatic Cancer1
- GIST - Gastrointestinal Stromal Tumor1
- CRC (Colorectal Cancer)1
Phoenix, Arizona1 trial
Los Angeles, California1 trial
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting
USC Norris Comprehensive Cancer Center
Phase 2
Denver, Colorado1 trial
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies
Sarah Cannon Research Institute at HealthONE
Phase 1
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.